Stock Analysis

Perimeter Medical Imaging AI Second Quarter 2024 Earnings: Beats Expectations

Published
TSXV:PINK

Perimeter Medical Imaging AI (CVE:PINK) Second Quarter 2024 Results

Key Financial Results

  • Net loss: US$3.18m (loss narrowed by 35% from 2Q 2023).
  • US$0.05 loss per share (improved from US$0.076 loss in 2Q 2023).
TSXV:PINK Earnings and Revenue History August 16th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Perimeter Medical Imaging AI Revenues and Earnings Beat Expectations

Revenue exceeded analyst estimates by 24%. Earnings per share (EPS) also surpassed analyst estimates by 37%.

Looking ahead, revenue is forecast to grow 61% p.a. on average during the next 3 years, compared to a 8.1% growth forecast for the Medical Equipment industry in North America.

Performance of the market in Canada.

The company's shares are down 16% from a week ago.

Risk Analysis

It is worth noting though that we have found 6 warning signs for Perimeter Medical Imaging AI (3 are concerning!) that you need to take into consideration.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.